Crucell corporate brochure (PDF)

Crucell’s commitment to the world – Taking responsibility – Appendix
Philanthropy overview
What we said (2009 target setting) What we did (2010 actions) Where we are (2010 outcomes) Where we are going (2010 target setting)
Number of doses donated
Report annually Donated 321,000 doses of MoRu-Viraten®
vaccine against measles and rubella to Unicef
to assist earthquake victims in Haiti
Support of sector sustainability initiatives
Further Crucell involvement Participated in a range of initiatives measuring
sustainability and CSR transparency: DJSI 1 ,
CDP 2 , GRI 3 and ‘Transparency Benchmark’ 4
NGO partnerships
Liaise with key NGOs and
evaluate partnership yearly
Conducted two Footprint field trips to
Bangladesh and planned a third trip which
was held early in 2011
Strengthened and expanded partnerships
with NGOs
Evaluated partnerships
1 DJSI – Dow Jones Sustainability indexes.
2 CDP – Carbon Disclosure Project.
3 GRI – Global Reporting Initiative.
4 Transparantiebenchmark (Transparency Benchmark),
an index published by the Dutch Ministry of Economic Affairs,
Innovation and Agriculture.
Quantitative
Qualitative
321,000 donated doses of MoRu-Viraten®
vaccine were shipped in August 2010
Self-declared GRI level C; DJSI listing
for second successive year
‘Transparency Benchmark’ score 96/200
Participation in CDP
Strong employee involvement in and
support for community outreach activities
Crucell–Friendship partnership is highly
successful in helping Bangladeshi
government to improve immunization
coverage in remote areas
In partnership with the Max Foundation
(new partner in 2010) Crucell is supporting
microsanitation projects in Bangladesh
Report annually
Global policy for disaster relief (donations)
Participation in DJSI, CDP and Transparency
Benchmark to end due to delisting
Continue participation in GRI
New Footprint fieldtrips scheduled for 2011
Further strengthen current NGO partnerships
Explore potential new partnerships
73